Tag: FDA

FDA Recognizes LSD-Equivalent Drug with ‘Breakthrough Therapy’ Label for Anxiety Relief

Encouraging outcomes from a clinical study on the LSD-analog substance MM120, or lysergide d-tartrate, have led the Food and Drug Administration (FDA) to designate it as a “breakthrough therapy” for treating generalized anxiety disorder (GAD). The designation of “breakthrough therapy” is awarded to expedite the development and review of drugs that show considerable promise in […]

FDA Gathers Public Social Media Data To Better Understand Cannabis Users As Part Of Its Effort Toward Rescheduling Marijuana

The Food and Drug Administration recently offered a glimpse into its comprehensive analysis justifying its recommendation to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act. CDER director Patrizia Cavazzoni explained that as part of the FDA’s “directive to explore whether marijuana should remain listed as Schedule 1 under the Controlled […]

Back To Top